Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC7853 GSK2801 Featured GSK2801 is a very potent inhibitor of the BAZ2 family of bromodomain containing proteins.
DC9719 Lp-PLA2 -IN-1(GSK2814338) Featured GSK2814338, also known as Lp-PLA2 -IN-1, is a Lp-PLA2 inhibitor
DC7847 HIV Inhibitor GSK2838232 Featured GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being developed for the treatment of chronic HIV infection.
DC22317 GSK-2894631A(HPGDS inhibitor 2) Featured GSK-2894631A,GSK 2894631A,GSK2894631A
DC9717 amyloid P-IN-1(GSK3039294) Featured GSK3039294 is a Serum amyloid P component inhibitor.
DC26011 GSK3145095 Featured GSK3145095 is an orally available, small-molecule inhibitor of RIPK1, with potential antineoplastic and immunomodulatory activities.
DC8505 GSK369796 Featured GSK369796 shows antimalerial activity with IC50 values of 11.2 nM for 3D7 strain, 12.6 nM for HB3 strain, 17.6 nM for K1 strain
DC22306 cGAS inhibitor 467 Featured GSK467 is a potent and selective inhibitor of KDM5 (also known as JARID1). GSK467 exploits unique binding modes.
DC12513 RIP1 inhibitor GSK547 Featured GSK547 (RIP1i, GSK 547) is a highly selective and potent inhibitor of RIP1 kinase that robustly targets RIP1 in vivo.
DC8373 GSK8573 Featured GSK-8573 is the inactive control of GSK-2801.
DC26130 GSK8612 Featured GSK8612 is a highly selective and potent Tank-binding Kinase-1 (TBK1) inhibitor, with a pIC50 of 6.8 for recombinant TBK1.
DC9907 GSK9311 Featured GSK9311 is a potent and highly selective inhibitor of the BRPF bromodomain (BRPDF1 pIC50 = 6.0; BRPDF2 pIC50 = 4.3).
DC10064 GSK-F1 Featured GSK-F1 is a potent inhibitor of PI4KA.
DC7858 GSK-J1 Featured GSK-J1 is a potent and selective inhibitor of the H3K27 histone demethylases JMJD3 and UTX (IC50 = 60 nM for human JMJD3 in vitro).
DC7857 GSK-LSD1 Featured GSK-LSD1 is a potent and selective inhibitor of lysine specific demethylase 1 (LSD1).
DC23890 GSM-1 GSM-1 (GSM1) is a γ-secretase modulator that directly targets the transmembrane domain (TMD) 1 of presenilin 1, shows potent Aβ42-lowering effect (IC50=0.348 uM) in a cell-based assay.
DC23886 GSM-2 GSM-2 is a second-generation γ-secretase modulator (GSM) that only decreases Aβ42 (IC50=65.2 nM), while inversely increasing Aβ38 and having no effect on β-CTF and Aβ40 levels.
DC20399 GSTO1 inhibitor C1-27 GSTO1 inhibitor C1-27 is a potent, selective, covalent glutathione S-transferase omega 1 (GSTO1) inhibitor with IC50 of 31 nM.
DC20112 GT 949 Featured GT 949 is a selective excitatory amino acid transporter-2 (EAAT2) positive allosteric modulator with an EC50 of 0.26 nM.
DC21403 GTC 365 GTC-365 (NSC 177365) is a small drug-like pharmacological chaperone that induces cancer cell death by restoring tertiary DNA structures in mutant human telomerase reverse transcriptase (hTERT) promoters.
DC21404 GTC 365 hydrochloride GTC-365 (NSC 177365) is a small drug-like pharmacological chaperone that induces cancer cell death by restoring tertiary DNA structures in mutant human telomerase reverse transcriptase (hTERT) promoters.
DCAPI1387 Guaifenesin(Guaiphenesin) Guaifenesin(Guaiphenesin)
DC21825 Guanabenz Featured Guanabenz (WY 8678) is an α2 adrenergic receptor agonist that is used as an antihypertensive agent, also has been proposed to exert protective effects against misfolding by interfering with eIF2α-P dephosphorylation through selective disruption of a PP1-P
DC12076 Guanidinosuccinic acid Guanidinosuccinic acid is a nitrogenous metabolite isolated in excess from serum and urine.
DC23297 GUT-70 GUT-70 is a tricyclic coumarin derived from Calophyllum brasiliense, markedly reduces cell proliferation, viability through G1 cell cycle arrest and increases apoptosis.
DC23117 GV-58 GV-58 is a potent, selective N-Type and P/Q-type Ca2+ Channel agonist with EC50 of 7.2 and 8.8 uM, shows no acitivity for L-type calcium channels (EC50>100 uM).
DC21102 GW 275175X GW 275175X is a derivative of BDCRB that displays anti-HCMV activity by inhibition of viral DNA maturation.
DC23402 GW 841819X GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain that displays activity in vivo against NUT-midline carcinoma, multiple myeloma, mixed-lineage leukemia, and acute myeloid leukemia..
DC23142 GW274150 Featured GW274150 is a novel arginine-competitive, NADPH-dependent iNOS inhibitor that has been identified from a series of acetamide amino acids that have a high selectivity for iNOS vs both eNOS (> 260-fold) and nNOS (> 219-fold) and high bioavailability (> 90%) after oral administration.Target: iNOSin vivo: GW274150 demonstrates a narrow neuroprotective therapeutic window against the toxic actions of 6-OHDA. GW274150 administration leads to a dose-dependent decrease in the number of iNOS-positive cells in the SNc of the 6-OHDA-lesioned animals. The iNOS inhibitor GW274150 fails to produce long-term neuroprotection after its withdrawal in the 6-OHDA-lesioned rat. [1]
DC8193 GW311616A GW311616A is a potent, intracellular human neutrophil elastase (HNE, α-1-proteinase) inhibitor.

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X